1. Home
  2. UPC vs REVB Comparison

UPC vs REVB Comparison

Compare UPC & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • REVB
  • Stock Information
  • Founded
  • UPC 1998
  • REVB 2020
  • Country
  • UPC China
  • REVB United States
  • Employees
  • UPC 225
  • REVB N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • REVB Health Care
  • Exchange
  • UPC Nasdaq
  • REVB Nasdaq
  • Market Cap
  • UPC 1.2M
  • REVB 1.4M
  • IPO Year
  • UPC 2021
  • REVB N/A
  • Fundamental
  • Price
  • UPC $0.68
  • REVB $0.34
  • Analyst Decision
  • UPC
  • REVB
  • Analyst Count
  • UPC 0
  • REVB 0
  • Target Price
  • UPC N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • UPC 803.8K
  • REVB 1.7M
  • Earning Date
  • UPC 01-01-0001
  • REVB 11-08-2024
  • Dividend Yield
  • UPC N/A
  • REVB N/A
  • EPS Growth
  • UPC N/A
  • REVB N/A
  • EPS
  • UPC N/A
  • REVB N/A
  • Revenue
  • UPC $26,725,919.00
  • REVB N/A
  • Revenue This Year
  • UPC N/A
  • REVB N/A
  • Revenue Next Year
  • UPC N/A
  • REVB N/A
  • P/E Ratio
  • UPC N/A
  • REVB N/A
  • Revenue Growth
  • UPC N/A
  • REVB N/A
  • 52 Week Low
  • UPC $0.12
  • REVB $0.32
  • 52 Week High
  • UPC $4.32
  • REVB $25.26
  • Technical
  • Relative Strength Index (RSI)
  • UPC 34.30
  • REVB 27.29
  • Support Level
  • UPC $0.63
  • REVB $0.32
  • Resistance Level
  • UPC $4.93
  • REVB $0.47
  • Average True Range (ATR)
  • UPC 0.45
  • REVB 0.08
  • MACD
  • UPC 0.08
  • REVB -0.02
  • Stochastic Oscillator
  • UPC 1.26
  • REVB 3.40

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: